Stay updated on Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Publications section wording now states automatic population from PubMed and the page revision is updated to v3.3.2, replacing the previous wording and revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T21:24:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The top government funding/operating status notice on the study details page has been removed.
    Difference
    0.3%
    Check dated 2025-11-17T19:17:17.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    No significant changes to core content were detected; only minor formatting adjustments observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T13:43:09.000Z thumbnail image
  5. Check
    62 days ago
    Change Detected
    Summary
    Major update adds a government operations notice and NIH Clinical Center status with a v3.2.0 release; removes a specific resource (Small cell lung carcinoma) from the GARD list and drops the v3.1.0 reference.
    Difference
    2%
    Check dated 2025-10-06T04:22:54.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Updated the page version from v3.0.2 to v3.1.0; no other content changes detected.
    Difference
    0.0%
    Check dated 2025-09-28T23:39:18.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Updated from v3.0.1 to v3.0.2, indicating a new patch release; the Back to Top link was removed as a minor UI change. No other substantive changes to core content were detected.
    Difference
    0.1%
    Check dated 2025-09-14T09:59:12.000Z thumbnail image

Stay in the know with updates to Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate Clinical Trial page.